Trial intelligence / Profile preview

Ultrasound-guided superior laryngeal nerve block for postoperative sore throat after NIM EMG endotracheal intubation

ChiCTR2300076939Phase 4Completed

Sponsor
Shanghai Sixth People's Hospital
Start
Nov 2023
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in Post-extubation sore throat (POST) comparing Ropivacaine superior laryngeal nerve block with Saline superior laryngeal nerve block (placebo) (2 arms). Primary endpoint: Incidence of postoperative sore throat (POST). Started Nov 2023; status: completed.

02

Drugs

ropivacaine
03

Conditions

Post-extubation sore throat (POST)

Beyond the preview

Go deeper on ChiCTR2300076939.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300076939.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call